Article PDF
Rights and permissions
About this article
Cite this article
Anderson, C. US company's gene therapy trial is first to bypass RAC for approval. Nature 357, 615 (1992). https://doi.org/10.1038/357615a0
Issue Date:
DOI: https://doi.org/10.1038/357615a0